Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis

被引：0
|
作者：
James Patrick Finnerty
Aravind Ponnuswamy
Prosjenjit Dutta
Ammar Abdelaziz
Hafiz Kamil
机构：
[1] Countess of Chester Hospital NHS Trust,Department of Respiratory Medicine
[2] University of Chester Medical School,undefined
[3] The Walton Centre,undefined
来源：
BMC Pulmonary Medicine | / 21卷
关键词：
Idiopathic pulmonary fibrosis; Nintedanib; Pirfenidone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS (IPF)
    FULMER, J
    ELSON, N
    GAL, EV
    MCLEES, B
    DEMETS, D
    WEINBERGER, S
    KELMAN, J
    CRYSTAL, R
    CLINICAL RESEARCH, 1978, 26 (03): : A538 - A538
  • [22] The efficacy and safety of pirfenidone in the treatment of HPS-related pulmonary fibrosis and Idiopathic pulmonary fibrosis: a systematic review and meta-analysis
    Ma, Y. -J.
    Zhang, Q.
    Wang, C. -X.
    Wu, W.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (22) : 8411 - 8424
  • [23] LONG-TERM NINTEDANIB TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Song, Jin Woo
    Quaresma, Manuel
    Kaye, Mitchell
    Stansen, Wibke
    Stowasser, Susanne
    Kreuter, Michael
    RESPIROLOGY, 2017, 22 : 46 - 46
  • [24] Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF)
    Balestro, Elisabetta
    Turato, Graziella
    Biondini, Davide
    Pavanello, Sofia
    Fraccaro, Alessia
    Rigobello, Chiara
    Bazzan, Erica
    Campisi, Manuela
    Baraldo, Simonetta
    Cosio, Manuel
    Saetta, Marina
    Spagnolo, Paolo
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [25] Mechanisms of treatment response to pirfenidone of idiopathic pulmonary fibrosis (IPF) patients
    Ronan, Nicola
    Khan, Kashif A.
    Subramaniam, Abirami
    McCarthy, Yvonne
    Burke, Louise
    Chelliah, A.
    Plant, Barry J.
    Henry, Michael T.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [26] Clinical experience with Nintedanib for treatment of idiopathic pulmonary fibrosis (IPF) in Spain
    Valenzuela, Claudia
    Molina, Maria Molina
    Portal, Jose Antonio Rodriguez
    Ortiz, Romero
    Cano, Esteban
    Nieto, Maria Jesus Rodriguez
    Laporta, Rosalia
    Ancochea, Julio
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [27] Treatments For Idiopathic Pulmonary Fibrosis (ipf): A Systematic Review, Network Meta-Analysis And Economic Evaluation
    Loveman, E.
    Copley, V. R.
    Colquitt, J. L.
    Scott, D. A.
    Clegg, A. J.
    Jones, J.
    O'Reilly, K. M.
    Singh, S. J.
    Bausewein, C.
    Wells, A. U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [28] The development of a measure to better understand patient experiences with pirfenidone and nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF)
    Wijsenbeek-Lourens, Marlies S.
    Kimman, Merel L.
    Rotteveel, Adrienne
    van Jaarsveld, Xana
    Weinreich, Stephanie S.
    Mostard, Remy
    Dirksen, Carmen D.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [29] Nebulised pirfenidone in non-idiopathic pulmonary fibrosis (IPF) progressive pulmonary fibrosis (PPF): first look at FVC data
    West, Alex
    Lawrence, Alexandra
    Bao, Hao
    Nair, Deepthi
    Thompson, Courtney
    Woodhead, Felix
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [30] Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
    Takaiwa, Takuya
    Tachibana, Hiromasa
    Arita, Machiko
    Ishida, Tadashi
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
12345